5 Broker-Adored Stocks to Monitor as 2025 Nears Its End

As 2025 winds down, brokers favor ZUMZ, BODI, CVI, CIVI, and ADNT. These stocks show earnings strength and valuation appeal.

Zacks Investment Research • Dec 10, 2025

Adient Formed a Joint Venture with SCI to Drive Growth in China

SHANGHAI , Dec. 8, 2025 /PRNewswire/ -- Recently, Adient, a global leader in automotive seating, completed the acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd., a local Chinese supplier under Zhejiang Yoening Technology Group, officially establishing a new strategic joint venture.

PRNewsWire • Dec 8, 2025

Why Is Adient (ADNT) Down 0.1% Since Last Earnings Report?

Adient (ADNT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 5, 2025

Adient Q4 Earnings Miss Expectations, Revenues Rise Y/Y

ADNT posts higher Q4 sales but misses EPS forecasts as segment margins narrow and FY26 outlook points to lower revenues and EBITDA.

Zacks Investment Research • Nov 7, 2025

Adient plc (ADNT) Q4 2025 Earnings Call Transcript

Adient plc ( ADNT ) Q4 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Linda Conrad Jerome Dorlack - President, CEO & Director Mark Oswald - Executive VP & CFO Conference Call Participants Colin Langan - Wells Fargo Securities, LLC, Research Division Emmanuel Rosner - Wolfe Research, LLC Dan Levy - Barclays Bank PLC, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Joseph Spak - UBS Investment Bank, Research Division Presentation Operator Welcome to the Adient's Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] I'd like to inform all participants that today's call is being recorded.

Seeking Alpha • Nov 5, 2025

Adient reports solid fourth quarter and full-year 2025 financial results; provides full-year FY26 outlook

PLYMOUTH, Mich. , Nov. 5, 2025 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its fourth quarter 2025 financial results.

PRNewsWire • Nov 5, 2025

Compared to Estimates, Adient (ADNT) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Nov 5, 2025

Adient (ADNT) Q4 Earnings Miss Estimates

Adient (ADNT) came out with quarterly earnings of $0.52 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.68 per share a year ago.

Zacks Investment Research • Nov 5, 2025

Adient (ADNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 29, 2025

Adient (ADNT) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Oct 24, 2025